Literature DB >> 453307

The ultrasonographic and radiologic features of a histologically proven case of alveolar soft-part sarcoma of the orbit.

G D Grant, J A Shields, J C Flanagan, P Horowitz.   

Abstract

An 18-year-old woman had a rapidly progressive proptosis, vascular congestion, and orbital pain. Ultrasonographic and radiologic tests supported the diagnosis of a solid vascularized mass that proved histologically to be an alveolar soft-part sarcoma of the orbit. Uncertainty as to the histogenesis of alveolar soft-part sarcoma still exists, but prognosis for patient survival is poor.

Entities:  

Mesh:

Year:  1979        PMID: 453307     DOI: 10.1016/0002-9394(79)90352-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Infratemporal alveolar soft part sarcoma: CT, MRI and angiographic findings.

Authors:  M Castillo; Y Y Lee; S Yamasaki
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  Rare Case Report of Alveolar Soft Part Sarcoma of the Orbit.

Authors:  G Kranthi Kumar; Hemant Nemade; Daphne Fonseca; L M Chandra Sekhara Rao; T Subramanyeshwar Rao
Journal:  Indian J Surg Oncol       Date:  2016-08-27

3.  Orbital alveolar soft part sarcoma: Histopathologic report of two cases.

Authors:  Hind Alkatan; Ahlam A Al-Shedoukhy; Imtiaz A Chaudhry; Ayman Al-Ayoubi
Journal:  Saudi J Ophthalmol       Date:  2010-06-02

4.  Alveolar soft-part sarcoma.

Authors:  R Hurt; M Bates; W Harrison
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

5.  Alveolar soft part sarcoma of the superior rectus muscle: Case report and review of literature.

Authors:  Seyed Mohsen Rafizadeh; Kasra Cheraqpour; Fahimeh Asadi Amoli; Ali A Haydar
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-03

Review 6.  Paediatric orbital alveolar soft part sarcoma recurrence during long-term follow-up: a report of 3 cases and a review of the literature.

Authors:  Yujiao Wang; Baixue Du; Mei Yang; Weimin He
Journal:  BMC Ophthalmol       Date:  2020-02-21       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.